0
2021
Over The Counter (otc) Test Market

Over The Counter (OTC) Test Market

by Product Type (Glucose Monitoring Test, Pregnancy & Fertility test, Coagulation Monitoring Test, Urinalysis Test, Cholesterol Test, and Other Test), Technology (Lateral Flow Assays, Immunoassays, and Dipsticks), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021--2030

Report Code: A10465
Pages: 353
Oct 2021 | 4170 Views
Author(s) : Linu D , Onkar S
Tables: 176
Charts: 54
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Over The Counter (otc) Test Market

Request Now !

The global over-the-counter (OTC) test market size was valued at $13,498.50 million in 2020, and is estimated to reach $39,937.90 million by 2030, growing at a CAGR of 11.7% from 2021 to 2030. Over-the-counter (OTC) testing medical devices are directly available to the consumer and they do not require a prescription for sale. They can be used outside healthcare facilities, such as home, school, office, and communities. The over-the-counter testing products are adequately labelled with proper instruction such that the consumer is able to understand its usage, without any help from a physician. According to Food and Drug Administration (FDA), the safety margin of over-the-counter medical device and testing products are such that the benefits of having an available over-the-counter device outweighs the risks. 

The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global over-the-counter test market. The COVID-19 pandemic has stressed the healthcare systems in the world and increased the need for the development of advanced at-home over-the-counter testing product. Increase in the spread of COVID-19 infection surged the demand for over-the-counter COVID-19 test kit.

Growth of the global over-the-counter test market is majorly driven by increase in prevalence of chronic and infectious disease such as heart disease, diabetics, respiratory infection; rise in demand for point-of-care, over-the-counter diagnostic test; increase in funding from private & government organizations for development of pharmaceutical and biotechnology industry; and advancements in technologies for over-the-counter test products. According to the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that approximately 1.7 million infections and 99,000 associated deaths occur every year in American hospitals. 

Over-the-Counter-Test-Market

Furthermore, surge in demand for point-of-care testing is anticipated to fuel the growth of the over-the-counter (OTC) test market. For instance, in April 2021, Food and Drug Administrative (FDA), announced the approval of over-the-counter (over-the-counter) and point-of-care (POC) testing for COVID-19. The combination of POC and over-the-counter test products such as Abbott BinaxNOW COVID-19 Ag self-test, Quidel Quicdel QuickVue at-home over-the-counter COVID-19 test and BD veritor system are used for detecting and screening of respiratory infection in school, workplaces, and communities. In addition, rise in geriatric population fuels the OTC market growth, owing to the fact that aged individuals are susceptible to chronic and infectious diseases. According to the U.S. Food and Drug Administration (FDA), in 2020, it was reported that around 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year.

Moreover, in 2018, Roche, a multinational healthcare company, announced the launch of CoaguCheck vantus system, which is a self-test device designed with advanced feature for monitoring blood coagulation, specially for patient on warfarin therapy. Thus, technological advancements in development of over-the-counter test and rise in awareness among individual regarding early diagnosis propel the growth of the OTC test market. However, high cost associated with over-the-counter test products is expected to restrict the over-the-counter market growth during the forecast period.

Over-the-counter Test Market Segmentation

The over-the-counter test market is segmented into product type, technology, distribution channel, and region. By product type, the market is categorized into glucose monitoring test, pregnancy & fertility test, coagulation monitoring test, urinalysis test, cholesterol test, and other test. The glucose monitoring test segment is further classified into blood glucose meters, testing strips, and lancets. The pregnancy & fertility test segment is further divided into pregnancy test and fertility test.

Depending on technology, it is categorized into lateral flow assays, immunoassays, and dipsticks. By distribution channel, the OTC test market is fragmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Over The Counter (OTC) Test Market
By Product

Your browser does not support the canvas element.

Glucose Monitoring Tests segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment Review

Depending on product type, the glucose monitoring test segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in prevalence of diabetics, and surge in demand for glucometer. However, the pregnancy & fertility test segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of infertility disorder, increasing birth rate, availability of the fertility testing device, and advancement in technology to develop pregnancy and fertility test product.

Over The Counter (OTC) Test Market
By Technology

Your browser does not support the canvas element.

Lateral Flow Assays segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of technology, the lateral flow assays segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to rise in prevalence of infectious diseases, increasing number of key players for manufacturing of lateral flow assay kits and surge in demand for home based lateral flow assay devices However, the immunoassays segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of chronic disease, advancement in technology for development of advanced immunoassays, and increase in demand for immunoassay for detection of antibody.

By distribution channel, the hospital pharmacies segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to rise in prevalence of diabetics, surge in demand for self-monitoring devices and initiative taken by government for advancement of hospital pharmacy. However, the online pharmacies segment is expected to witness considerable growth during the forecast period, due to advancement in technology in the healthcare sector and a rise in demand for remote service.

Over The Counter (OTC) Test Market
By Distribution Channel

Your browser does not support the canvas element.

Hospital Pharmacy segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America garnered the major share in the over-the-counter test market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of chronic disease, increase in number of approval for over-the-counter test product, the presence of key players, and development in technology for healthcare in the region. However, Asia-Pacific is expected to register the highest CAGR of 13.2% from 2021 to 2030, owing to increase in prevalence of chronic and infectious disease, rise in number of geriatric population, growth in health care expenditures, and rise in adoption of over-the-counter test product.

The key players operating in the global over-the-counter test market include Abbott Laboratories, Abingdon Health PLC, AccuBioTech Co., Ltd., Acon Laboratories Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Clip Health, Dario Health Corp, Ellume Health Ltd, Eurofins Scientific Group, F. Hoffmann-La Roche AG, Lia Diagnostics Inc, Lifescan IP Holdings, LLC, Lucira Health, Inc, Now Diagnostics Inc, Orasure Technologies Inc, PHC Holdings Corporation, Quidel Corporation, SD Biosensor Inc., and Sinocare Inc.

Over The Counter (OTC) Test Market
By Region

2030
North America 
Europe
Asia-Pacific
LAMEA

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the over-the-counter test market, and the current trends & future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing OTC test market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the over-the-counter test market.

Key Market Segments

By Product Type

  • Glucose Monitoring Test
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
  • Pregnancy & Fertility Test
    • Pregnancy Test
    • Fertility Test
  • Coagulation Monitoring Test
  • Urinalysis Test
  • Cholesterol Test
  • Other Test

By Technology

  • Lateral Flow Assays
  • Immunoassays
  • Dipsticks

By Distribution Channel

  • Hospital Pharmacy 
  • Retail Pharmacy
  • Online pharmacy

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players 

  • Abbott Laboratories
  • Abingdon Health PLC 
  • AccuBioTech Co., Ltd. 
  • Acon Laboratories Inc. 
  • B. Braun Melsungen AG 
  • Becton Dickinson and Company
  • Clip Health 
  • Dario Health Corp
  • Ellume Health Ltd
  • Eurofins Scientific Group
  • F. Hoffmann-La Roche AG 
  • Lia Diagnostics Inc
  • Lifescan IP Holdings, LLC
  • Lucira Health, Inc
  • Now Diagnostics Inc
  • Orasure Technologies Inc
  • PHC Holdings Corporation 
  • Quidel Corporation 
  • SD Biosensor Inc.
  • Sinocare Inc.

Over The Counter (OTC) Test Market Report Highlights

Aspects Details
By PRODUCT TYPE
  • Glucose Monitoring Tests
    • Blood Glucose meters
    • Testing strips
    • Lancets
  • Pregnancy & Fertility Tests
    • Pregnancy Test
    • Fertility Test
  • Coagulation Monitoring Tests
  • Urinalysis Tests
  • Cholesterol Tests
  • Other Tests
By TECHNOLOGY
  • Lateral Flow Assays
  • Immunoassays
  • Dipsticks
By DISTRIBUTION CHANNEL
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Abingdon Health PLC, Clip Health, .B. Braun Melsungen AG, Acon Laboratories, INC., Abbott Laboratories, Ellume Health Ltd., Eurofins Scientific Group, .AccuBioTech Co., Ltd, Becton, Dickinson and Company, Dario Health Corp.
 

Loading Table Of Content...


 
 

Growth of the over-the-counter test market is attributed to factors such as technological advancements in the healthcare sector; rise in prevalence of chronic and infectious diseases such as diabetic, cardiovascular disease, HIV, & COVID-19; increase development of healthcare sector for manufacturing advanced over-the-counter test products; and rise in awareness about early diagnosis. The over-the-counter test market gains interest of pharmaceutical and biotechnology companies, owing to surge in demand for point-of-care over-the-counter diagnostic testing. This leads to increase in adoption of over-the-counter testing for detection and monitoring of chronic diseases. Moreover, advancement in technology, such as lateral flow assay, immunoassay, and dipstick, have gained high traction in the market in recent years, as these having its application in over-the-counter test products.

North America is expected to witness the highest growth, in terms of revenue, owing to rise in prevalence of chronic disease, increase in number of approval for over-the-counter test product, the presence of key players, and development in technology for healthcare in the region.

Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in prevalence of chronic and infectious disease, rise in number of geriatric population, growth in health care expenditures, and rise in adoption of over-the-counter test product.

However, high cost associated with over-the-counter testing products is anticipated to restrain the market growth during the forecast period.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Over the Counter Test market is $13,498.5 million in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of Over the Counter Test market in 2021 was $14,741.71 million

A. Yes, Over the Counter Test companies are profiled in the report

A. The top companies that hold the market share in Over the Counter Test market are Abbott Laboratories, Abingdon Health PLC, AccuBioTech Co., Ltd., Acon Laboratories Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Clip Health, Dario Health Corp, Ellume Health Ltd, Eurofins Scientific Group, F. Hoffmann-La Roche AG, Lia Diagnostics Inc, Lifescan IP Holdings, LLC, Lucira Health, Inc, Now Diagnostics Inc, Orasure Technologies Inc, PHC Holdings Corporation, Quidel Corporation, SD Biosensor Inc., and Sinocare Inc

A. Asia-Pacific is expected to register the highest CAGR of 13.2% from 2021 to 2030, owing to increase in prevalence of chronic and infectious disease, rise in number of geriatric population, growth in health care expenditures, and rise in adoption of over the counter tests product

A. The key trends in the Over the Counter Test market are by increase in prevalence of chronic and infectious disease such as heart disease, diabetics, respiratory infection; rise in demand for point-of-care over-the-counter diagnostic test; increase in funding from private & government organizations for development of pharmaceutical and biotechnology industry; and advancements in technologies for over the counter tests products.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Over The Counter (otc) Test Market

Start reading instantly.
This Report and over 53,854+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers